著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Takashi Seto and Terufumi Kato and Makoto Nishio and Koichi Goto and Shinji Atagi and Yukio Hosomi and Noboru Yamamoto and Toyoaki Hida and Makoto Maemondo and Kazuhiko Nakagawa and Seisuke Nagase and Isamu Okamoto and Takeharu Yamanaka and Kosei Tajima and Ryosuke Harada and Masahiro Fukuoka and Nobuyuki Yamamoto,"Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study",The Lancet Oncology,1470-2045,Elsevier BV,2014-10,15,11,1236-1244,https://cir.nii.ac.jp/crid/1360002216450157952,https://doi.org/10.1016/s1470-2045(14)70381-x